Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7533667rdf:typepubmed:Citationlld:pubmed
pubmed-article:7533667lifeskim:mentionsumls-concept:C0238461lld:lifeskim
pubmed-article:7533667lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:7533667pubmed:issue4lld:pubmed
pubmed-article:7533667pubmed:dateCreated1995-4-13lld:pubmed
pubmed-article:7533667pubmed:abstractTextAnaplastic carcinoma of the thyroid is a tumour of advanced age, with a female/male ratio of 2/1. Its incidence is of 1-2 cases/million/year. The tumour is one of the most aggressive neoplasms affecting humans. It spreads very rapidly to the regional lymph nodes and causes distant metastases, in particular in the lungs and bone. Surgery, external radiation or chemotherapy are usually ineffective when used alone. Better results are obtained by combinations of these modalities, in particular by a combination of radiotherapy and chemotherapy followed by surgery. In our Centre we have, since 1991, adopted a multimodal treatment based on radiotherapy preceded by Cisplatin administration, followed by surgery and then by adjuvant chemotherapy with Adriamycin and Bleomycin. The initial results on a limited number of cases seem encouraging.lld:pubmed
pubmed-article:7533667pubmed:languageitalld:pubmed
pubmed-article:7533667pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7533667pubmed:citationSubsetIMlld:pubmed
pubmed-article:7533667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7533667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7533667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7533667pubmed:statusMEDLINElld:pubmed
pubmed-article:7533667pubmed:issn0009-4773lld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:DanieleOOlld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:BusnardoBBlld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:GirelliM EMElld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:PelizzoM RMRlld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:NacamulliDDlld:pubmed
pubmed-article:7533667pubmed:authorpubmed-author:RigonAAlld:pubmed
pubmed-article:7533667pubmed:issnTypePrintlld:pubmed
pubmed-article:7533667pubmed:volume46lld:pubmed
pubmed-article:7533667pubmed:ownerNLMlld:pubmed
pubmed-article:7533667pubmed:authorsCompleteYlld:pubmed
pubmed-article:7533667pubmed:pagination37-41lld:pubmed
pubmed-article:7533667pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:meshHeadingpubmed-meshheading:7533667-...lld:pubmed
pubmed-article:7533667pubmed:year1994lld:pubmed
pubmed-article:7533667pubmed:articleTitle[Undifferentiated carcinoma of the thyroid gland].lld:pubmed
pubmed-article:7533667pubmed:affiliationIstituto di Semeiotica Medica, Università degli Studi di Padova.lld:pubmed
pubmed-article:7533667pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7533667pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7533667pubmed:publicationTypeEnglish Abstractlld:pubmed